AdvisorShares Pure US Cannabis ETF (MSOS)
| Assets | $891.81M |
| Expense Ratio | 0.77% |
| PE Ratio | 12.20 |
| Shares Out | 188.23M |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| Volume | 1,529,758 |
| Open | 4.750 |
| Previous Close | 4.750 |
| Day's Range | 4.660 - 4.775 |
| 52-Week Low | 2.020 |
| 52-Week High | 7.605 |
| Beta | 1.20 |
| Holdings | 117 |
| Inception Date | Sep 1, 2020 |
About MSOS
Fund Home PageThe AdvisorShares Pure US Cannabis ETF (MSOS) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed narrow portfolio of US stocks or swap contracts related to the domestic cannabis and hemp industry. MSOS was launched on Sep 1, 2020 and is issued by AdvisorShares.
Top 10 Holdings
131.68% of assets| Name | Symbol | Weight |
|---|---|---|
| Derivatives Collateral Nomura | n/a | 44.68% |
| Green Thumb Industries Swap | n/a | 14.03% |
| Curaleaf Holdings Inc Swap | n/a | 12.58% |
| Trulieve Cannabis Swap | n/a | 12.39% |
| BlackRock Treasury Trust Fund | TTTXX | 12.35% |
| Derivatives Collateral Nbc | n/a | 10.90% |
| Curaleaf Holdings, Inc. | CURA | 9.21% |
| Derivatives Collateral Cf Secured | n/a | 6.56% |
| Verano Holdings Corp Swap | n/a | 4.80% |
| Derivatives Collateral Marex | n/a | 4.19% |
Performance
MSOS had a total return of -38.34% in the past year, including dividends. Since the fund's inception, the average annual return has been -27.85%.
News
Cannabis stocks soar after Trump shares video promoting drug's use for seniors
Video posted on Truth Social touts CBD as a ‘gamechanger' and promotes Medicaid coverage of CBD products
Cannabis stocks move higher after Trump boasts CBD health benefits
Cannabis stocks got a pop on Monday after President Trump shared a video highlighting potential health benefits of CBD, reigniting speculation that his administration could reclassify the drug, CNBC's...
President Trump Lights Up Cannabis Stocks With Pro-CBD Truth Social Post
President Donald Trump posted a video on Truth Social on Sunday, promoting the potential health benefits of cannabis. Cannabis stocks lit up on Monday after Trump resurrected hopes for a change in fed...
Quant Buys In Cannabis
Cannabis has bipartisan support, but is it worthy of your investment? Quant Strategist Emma Johnston on how quant thinks about sector ETF MSOS, currently rated a buy due to strong momentum and liquidi...
MSOS: Cannabis Investors Betting Big On Trump
Optimism that the Trump administration will soon reschedule cannabis, thereby removing the Section 280E tax burden and boosting sector profitability, has fueled a dramatic rally in cannabis stocks. MS...
Rescheduling Should Send MJ And MSOS Sky High
Cannabis stocks and ETFs like Amplify Alternative Harvest ETF and AdvisorShares Pure US Cannabis ETF are surging on speculation that President Trump will reclassify marijuana as a Schedule III drug. R...
Cannabis stocks rally after Trump says he is weighing drug reclassification
Cannabis stocks rallied Monday after President Donald Trump said he is considering reclassifying marijuana, which would categorize it as less of a danger to public safety.
Cannabis stocks rally on Wall Street Journal report that Trump is weighing drug reclassification
Cannabis stocks rallied on a Wall Street Journal report that President Donald Trump is contemplating reclassifying weed as having a lower danger level. Such a move would be "a gamechanger" for the ind...
MSOS: Headed For A New All-Time Low
MSOS has significantly underperformed the broader cannabis market, dropping 41.2% YTD versus a 27.8% sector decline. I downgraded MSOS to Strong Sell in April due to persistent risks, and the ETF has ...
MSOS ETF Underperforms Compared To Canadian Cannabis Peers
MSOS holds US cannabis MSOs exclusively. It allows for exposure to US cannabis companies. US MSO stocks are historically down.
MJ And MSOS: Cannabis' Inevitable Legalization Offers High Upside Despite Blunt Risks
Cannabis legalization is inevitable, driven by shifting political, generational, and fiscal dynamics, especially as Republicans seek votes and tax revenue. Despite high risks, the upside for cannabis ...
Hedge Fund Veteran Doug Kass Says Most Cannabis Stocks Are 'Walking Dead,' But These 4 Names Stand Out
Veteran hedge fund manager Doug Kass isn't mincing words about the state of the cannabis industry. In a recent column titled “Picking the Cannabis Winners in an Industry Full of the Walking Dead,” the...
Why Cannabis Stocks Jumped By Double Digits And Why Analysts Say 'Don't Drink The Kool-Aid In One Gulp'
Author's note: this article has been updated to include more context and commentary from analysts.
Sell MSOS And Its 3 Largest Holdings
I am downgrading MSOS (and its top holdings to Strong Sell or Sell), to Strong Sell due to ongoing 280E taxation concerns and poor market performance. MSOS has seen significant redemptions since March...
Cannabis stocks climb on RFK Jr. approval, Senate marijuana-banking hearing
Cannabis stocks tend to move on speculation around potential federal reforms around pot.
MSOS: High Risk/Reward On The Cannabis Market
The AdvisorShares Pure US Cannabis ETF offers a high-risk/high-reward opportunity, especially if cannabis is rescheduled to Schedule III in 2025. MSOS is an actively managed ETF focused on US cannabis...
Undercovered ETFs: Parking Cash, CLOs, Bonds, Mexico +
The 'Undercovered' Dozen series highlights lesser-covered ETFs, offering insights from various authors on potential opportunities and trends in this space. The Janus Henderson AAA CLO ETF (JAAA) inves...
MSOS Has Crashed But May Rebound
AdvisorShares Pure US Cannabis ETF has plummeted 65% since last year, with recent declines driven by Florida's failed legalization vote and MJUS liquidation news. MSOS remains poorly diversified, with...
Gaetz as Trump's AG seen as bullish for pot stocks, but confirmation looks unlikely
If controversial Republican Matt Gaetz manages to win confirmation as attorney general, his tenure at the Justice Department is expected to be positive for the cannabis industry.
Cannabis stocks plunge after DeSantis, Griffin win Florida fight against weed legalization
Amendment 3 – which would have legalized the recreational use of marijuana in the state's constitution – failed to receive the 60% support needed to pass under Florida law.
Cannabis stocks crater as Florida fails to garner needed votes for adult use
North Dakota and South Dakota also failed in their efforts to legalize cannabis for recreational use, while a medical measure passed in Nebraska.
AdvisorShares Highlights the Pending Historic Reforms in US Cannabis Market
With cannabis approaching a pivotal juncture, AdvisorShares provides key investment exposure to multi-state operators through its industry-leading ETF suite BETHESDA, Md. , Oct. 21, 2024 /PRNewswire/ ...
Navigating Volatility: MSOS ETF's Prospects In A Shifting Cannabis Landscape
The AdvisorShares Pure US Cannabis ETF offers targeted exposure to the U.S. cannabis industry, focusing on growth and value stocks despite recent volatility. Key catalysts include Biden's cannabis res...
Profit from the Green Wave: Top Cannabis Stocks to Watch
The cannabis sector has captivated investors, promising a green rush of potential profits. However, the path to profitability has been rocky, marked by regulatory hurdles, intense competition, and, at...
Why Cannabis Is Still An Excellent Long-Term Investment Opportunity
Cannabis investing requires a long-term timeline due to political delays and market volatility; patience is crucial for retail investors. Jesse Redmond highlights why Florida's potential legalization ...
Cannabis stocks rally after Trump supports moving drug to less restrictive category
GOP presidential nominee Donald Trump supports Schedule III classification for cannabis, which has already been proposed by the Biden administration.
Cannabis stocks post sharp gains as Trump says he's starting to ‘agree more' about reforms
Cannabis stocks moved sharply higher in late afternoon trading on Thursday after Republican presidential nominee Donald Trump said he's shifting his position in favor of looser cannabis laws.
MSOS: Opportunity And Frustration Ahead
Cannabis demand is high, but investing challenges hinder industry growth due to lack of federal framework. AdvisorShares Pure US Cannabis ETF focuses on US-based cannabis companies, excluding Canadian...
MSOS: The Dominos Are Falling
AdvisorShares Pure US Cannabis ETF invests in the cannabis industry through direct investments and derivatives. The top holdings of the ETF include Green Thumb Industries, Curaleaf Holdings, Trulieve ...
Looking For The Bud Light Of Cannabis
Alex Carchidi is bullish on the cannabis sector but not ready to invest in stocks, except for Innovative Industrial Properties. 2 cannabis stocks worth considering are Green Thumb Industries and Truli...
US reclassification could drive fresh research funding into pot sector
The U.S. pot sector could see an influx of medical research funding from healthcare investors amid renewed interest from pharmaceutical firms, should a proposal to reclassify cannabis as a lower-risk ...
Investors wary of US cannabis ETFs despite recent rally
Marijuana ETFs and cannabis stocks shot higher last week after the U.S. Justice Department said it plans to reclassify marijuana as a less dangerous drug.
Why investor appetite for commodity funds picked up despite ETF flows broadly seeing ‘pretty big drop' in April
Hello! This week's ETF Wrap digs into the slump in ETF flows in April and investor positioning around commodities as inflation worries persist.
Marijuana reclassified federally in major win for the legal cannabis industry
The U.S. government will reclassify marijuana as less risky as the recreational marijuana business continues to grow.
Here's the risk for buying TLRY, CGC, MSOS, and SNDL stocks
Cannabis stocks have gone parabolic. Tilray Brands (TLRY) stock jumped by over 39% on Tuesday while Canopy Growth (CGC) soared by over 78%.
U.S. poised to ease restrictions on marijuana in historic shift, though it'll remain controlled substance
WASHINGTON — The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press has learned, a historic shift to generations of American drug pol...
US plans to reclassify cannabis as less dangerous drug
The US is planning to reclassify cannabis as a less dangerous drug in an historic shift that could have a significant impact across the country.
Pot Stocks Rally as DEA Moves to Reclassify Marijuana as Less Dangerous Drug
Pot stocks rally as the DEA moves to reclassify marijuana as a less dangerous drug. Renita Young discusses this as the DEA's proposal needs to be reviewed by the White House Office of Management and B...
DEA to Reclassify Marijuana | Daily Stock Market Wrap 4/30
The stock market sank in the final stretch of April and bond yields climbed on concern that stubborn inflation will force the Federal Reserve to keep interest rates higher for longer. On the eve of th...
MSOS: Best Play On U.S. Cannabis Regulations
The U.S. Drug Enforcement Administration (DEA) is moving marijuana from Schedule I to Schedule III under the Controlled Substances Act, and pending approval from the White House Office of Management a...